{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T09:26:22Z","timestamp":1769246782194,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K18214"],"award-info":[{"award-number":["JP19K18214"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00428-021-03250-y","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:05:01Z","timestamp":1642982701000},"page":"831-841","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gene expression profiling using targeted RNA-sequencing to elucidate the progression from histologically normal lung tissues to non-invasive lesions in invasive lung adenocarcinoma"],"prefix":"10.1007","volume":"480","author":[{"given":"Taichi","family":"Kadonaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Sakabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiteru","family":"Kidokoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanae","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshige","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2846-390X","authenticated-orcid":false,"given":"Yoshihisa","family":"Umekita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"3250_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"3250_CR2","first-page":"26","volume-title":"WHO classification of tumors of the lung, pleura, thymus, and heart","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Bruke AP, Marx A, Nicholson AG (2015) WHO classification of tumors of the lung, pleura, thymus, and heart, 4th edn. IARC Press France, Lyon, pp 26\u201330","edition":"4"},{"key":"3250_CR3","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1038\/s41467-019-10877-8","volume":"10","author":"X Hu","year":"2019","unstructured":"Hu X, Fujimoto J, Ying L et al (2019) Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat Commun 10:2978. https:\/\/doi.org\/10.1038\/s41467-019-10877-8","journal-title":"Nat Commun"},{"key":"3250_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nm.2697","volume":"18","author":"W Pao","year":"2012","unstructured":"Pao W, Hutchinson KE (2012) Chipping away at the lung cancer genome. Nat Med 18:349\u2013351. https:\/\/doi.org\/10.1038\/nm.2697","journal-title":"Nat Med"},{"key":"3250_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"The Cancer Genome Atlas Research Network","year":"2014","unstructured":"The Cancer Genome Atlas Research Network (2014) Comprehensive molecular profiling of lung adenocarcinoma. Nature 511:543\u2013550. https:\/\/doi.org\/10.1038\/nature13385","journal-title":"Nature"},{"key":"3250_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nature12930","volume":"507","author":"TJ Desai","year":"2014","unstructured":"Desai TJ, Brownfield DG, Krasnow MA (2014) Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature 507:190\u2013194. https:\/\/doi.org\/10.1038\/nature12930","journal-title":"Nature"},{"key":"3250_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1101\/gad.338228.120","volume":"34","author":"G Ferone","year":"2020","unstructured":"Ferone G, Lee MC, Sage J, Berns A (2020) Cells of origin of lung cancers: lessons from mouse studies. Genes Dev 34:1017\u20131032. https:\/\/doi.org\/10.1101\/gad.338228.120","journal-title":"Genes Dev"},{"key":"3250_CR8","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1158\/0008-5472.can-13-1727","volume":"74","author":"SJ Murphy","year":"2014","unstructured":"Murphy SJ, Wigle DA, Lima JF et al (2014) Genomic rearrangements define lineage relationships between adjacent lepidic and invasive components in lung adenocarcinoma. Cancer Res 74:3157\u20133167. https:\/\/doi.org\/10.1158\/0008-5472.can-13-1727","journal-title":"Cancer Res"},{"key":"3250_CR9","doi-asserted-by":"publisher","first-page":"31628","DOI":"10.1038\/srep31628","volume":"6","author":"C Vinayanuwattikun","year":"2016","unstructured":"Vinayanuwattikun C, Le Calvez-Kelm F, Abedi-Ardekani B et al (2016) Elucidating genomic characteristics of lung cancer progression from in situ to invasive adenocarcinoma. Sci Rep 6:31628. https:\/\/doi.org\/10.1038\/srep31628","journal-title":"Sci Rep"},{"key":"3250_CR10","doi-asserted-by":"publisher","first-page":"13604","DOI":"10.1038\/s41598-020-70578-x","volume":"10","author":"T Nishimura","year":"2020","unstructured":"Nishimura T, Nakamura H, Tan KT et al (2020) A proteogenomic profile of early lung adenocarcinomas by protein co-expression network and genomic alteration analysis. Sci Rep 10:13604. https:\/\/doi.org\/10.1038\/s41598-020-70578-x","journal-title":"Sci Rep"},{"key":"3250_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1164\/rccm.201902-0294oc","volume":"201","author":"J Qian","year":"2020","unstructured":"Qian J, Zhao S, Zou Y, Rahman SMJ, Senosain MF, Stricker T, Chen H, Powell CA, Borczuk AC, Massion PP (2020) Genomic understandings of tumor behavior in in situ and early lung adenocarcinoma. Am J Respir Crit Care Med 201:697\u2013706. https:\/\/doi.org\/10.1164\/rccm.201902-0294oc","journal-title":"Am J Respir Crit Care Med"},{"key":"3250_CR12","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.1038\/s41467-019-13460-3","volume":"10","author":"H Chen","year":"2019","unstructured":"Chen H, Carrot-Zhang J, Zhao Y et al (2019) Genomic and immune profiling of pre-invasive lung adenocarcinoma. Nat Commun 10:5472. https:\/\/doi.org\/10.1038\/s41467-019-13460-3","journal-title":"Nat Commun"},{"key":"3250_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40169-015-0064-3","volume":"4","author":"Y Kato","year":"2015","unstructured":"Kato Y, Nakamura H, Tojo H et al (2015) A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types. Clin Transl Med 4:64. https:\/\/doi.org\/10.1186\/s40169-015-0064-3","journal-title":"Clin Transl Med"},{"key":"3250_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lungcan.2020.06.035","volume":"147","author":"Y Kidokoro","year":"2020","unstructured":"Kidokoro Y, Sakabe T, Haruki T, Kadonaga T, Nosaka K, Nakamura H, Umekita Y (2020) Gene expression profiling by targeted RNA sequencing in pathological stage I lung adenocarcinoma with a solid component. Lung Cancer 147:56\u201363. https:\/\/doi.org\/10.1016\/j.lungcan.2020.06.035","journal-title":"Lung Cancer"},{"key":"3250_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V (2016) The IASLC lung cancer staging project: TNM classification for lung cancer. J Thorac Oncol 11:39\u201351. https:\/\/doi.org\/10.1016\/j.jtho.2015.09.009","journal-title":"J Thorac Oncol"},{"key":"3250_CR16","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3250_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF et al (2003) PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267\u2013273. https:\/\/doi.org\/10.1038\/ng1180","journal-title":"Nat Genet"},{"key":"3250_CR18","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303","journal-title":"Genome Res"},{"key":"3250_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/bioinformatics\/btm554","volume":"24","author":"Y Assenov","year":"2008","unstructured":"Assenov Y, Ram\u00edrez F, Schelhorn SE, Lengauer T, Albrecht M (2008) Albrecht, computing topological parameters of biological networks. Bioinformatics 24:282\u2013284. https:\/\/doi.org\/10.1093\/bioinformatics\/btm554","journal-title":"Bioinformatics"},{"key":"3250_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/elife.43627","volume":"8","author":"H Basnet","year":"2019","unstructured":"Basnet H, Tian L, Ganesh K, Huang YH, Macalinao DG, Brogi E, Finley LW, Massagu\u00e9 J (2019) Flura-seq identifies organ-specific metabolic adaptations during early metastatic colonization. Elife 8:e43627. https:\/\/doi.org\/10.7554\/elife.43627","journal-title":"Elife"},{"key":"3250_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.lungcan.2018.11.035","volume":"127","author":"KH Pyo","year":"2019","unstructured":"Pyo KH, Kim JH, Lee JM, Kim SE, Cho JS, Lim SM, Cho BC (2019) Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models. Lung Cancer 127:112\u2013121. https:\/\/doi.org\/10.1016\/j.lungcan.2018.11.035","journal-title":"Lung Cancer"},{"key":"3250_CR22","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk D, Morris JH, Cook H et al (2017) The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 45:D362\u2013D368. https:\/\/doi.org\/10.1093\/nar\/gkw937","journal-title":"Nucleic Acids Res"},{"key":"3250_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cell.2020.06.012","volume":"182","author":"YJ Chen","year":"2020","unstructured":"Chen YJ, Roumeliotis TI, Chang YH et al (2020) Proteogenomics of non-smoking lung cancer in East Asia delineates molecular signatures of pathogenesis and progression. Cell 182:226-244.e217. https:\/\/doi.org\/10.1016\/j.cell.2020.06.012","journal-title":"Cell"},{"key":"3250_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette MA, Satpathy S, Cao S et al (2020) Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182:200-225.e235. https:\/\/doi.org\/10.1016\/j.cell.2020.06.013","journal-title":"Cell"},{"key":"3250_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/bdd.1892","volume":"35","author":"M Inazu","year":"2014","unstructured":"Inazu M (2014) Choline transporter-like proteins CTLs\/SLC44 family as a novel molecular target for cancer therapy. Biopharm Drug Dispos 35:431\u2013449. https:\/\/doi.org\/10.1002\/bdd.1892","journal-title":"Biopharm Drug Dispos"},{"key":"3250_CR26","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.3892\/mmr.2016.5136","volume":"13","author":"GZ Peng","year":"2016","unstructured":"Peng GZ, Ye QF, Wang R, Li MX, Yang ZX (2016) Knockdown by shRNA identifies SLC44A5 as a potential therapeutic target in hepatocellular carcinoma. Mol Med Rep 13:4845\u20134852. https:\/\/doi.org\/10.3892\/mmr.2016.5136","journal-title":"Mol Med Rep"},{"key":"3250_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvu260","volume":"105","author":"EH Moon","year":"2015","unstructured":"Moon EH, Kim YS, Seo J, Lee S, Lee YJ, Oh SP (2015) Essential role for TMEM100 in vascular integrity but limited contributions to the pathogenesis of hereditary haemorrhagic telangiectasis. Cardiovasc Res 105:353\u2013360. https:\/\/doi.org\/10.1093\/cvr\/cvu260","journal-title":"Cardiovasc Res"},{"key":"3250_CR28","doi-asserted-by":"publisher","first-page":"E643","DOI":"10.1002\/ijc.27426","volume":"131","author":"E Frullanti","year":"2012","unstructured":"Frullanti E, Colombo F, Falvella FS et al (2012) Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue. Int J Cancer 131:E643\u2013E648. https:\/\/doi.org\/10.1002\/ijc.27426","journal-title":"Int J Cancer"},{"key":"3250_CR29","unstructured":"Han Z, Wang T, Han S et al (2017) Low-expression of TMEM100 is associated with poor prognosis in non-small cell lung cancer. Am. J. Trans. Res 9:2567\u20132578. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/pmc5446537\/"},{"key":"3250_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3892\/or.2021.8014","volume":"45","author":"Q He","year":"2021","unstructured":"He Q, Dong Y, Zhu Y, Ding Z, Zhang X, Wang Z, Ai R, He Y (2021) TMEM100 induces cell death in non-small cell lung cancer via the activation of autophagy and apoptosis. Oncol Rep 45:63. https:\/\/doi.org\/10.3892\/or.2021.8014","journal-title":"Oncol Rep"},{"key":"3250_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1515\/hsz-2019-0161","volume":"401","author":"J Zhuang","year":"2020","unstructured":"Zhuang J, Huang Y, Zheng W, Yang S, Zhu G, Wang J, Lin X, Ye J (2020) TMEM100 expression suppresses metastasis and enhances sensitivity to chemotherapy in gastric cancer. Biol Chem 401:285\u2013296. https:\/\/doi.org\/10.1515\/hsz-2019-0161","journal-title":"Biol Chem"},{"key":"3250_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.153134","volume":"216","author":"Y Chen","year":"2020","unstructured":"Chen Y, Hu R, Li X, Shi Z, Tian H, Feng J, Yu S (2020) B7\u2013H4 and HHLA2, members of B7 family, are aberrantly expressed in EGFR mutated lung adenocarcinoma. Pathol Res Pract 216:153134. https:\/\/doi.org\/10.1016\/j.prp.2020.153134","journal-title":"Pathol Res Pract"},{"key":"3250_CR33","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1158\/1078-0432.Ccr-17-2924","volume":"24","author":"H Cheng","year":"2018","unstructured":"Cheng H, Borczuk A, Janakiram M, Ren X, Lin J, Assal A, Halmos B, Perez-Soler R, Zang X (2018) Wide expression and significance of alternative immune checkpoint molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers. Clin Cancer Res 24:1954\u20131964. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-2924","journal-title":"Clin Cancer Res"},{"key":"3250_CR34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1158\/1078-0432.Ccr-15-3071","volume":"23","author":"H Cheng","year":"2017","unstructured":"Cheng H, Janakiram M, Borczuk A, Lin J, Qiu W, Liu H, Chinai JM, Halmos B, Perez-Soler R, Zang X (2017) HHLA2, a new immune checkpoint member of the B7 family, is widely expressed in human lung cancer and associated with EGFR mutational status. Clin Cancer Res 23:825\u2013832. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-3071","journal-title":"Clin Cancer Res"},{"key":"3250_CR35","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1073\/pnas.1303524110","volume":"110","author":"R Zhao","year":"2013","unstructured":"Zhao R, Chinai JM, Buhl S et al (2013) HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function. Proc Natl Acad Sci 110:9879\u20139884. https:\/\/doi.org\/10.1073\/pnas.1303524110","journal-title":"Proc Natl Acad Sci"},{"key":"3250_CR36","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/his.13775","volume":"74","author":"Y Kai","year":"2019","unstructured":"Kai Y, Amatya VJ, Kushitani K, Kambara T, Suzuki R, Tsutani Y, Miyata Y, Okada M, Takeshima Y (2019) Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma. Histopathology 74:545\u2013554. https:\/\/doi.org\/10.1111\/his.13775","journal-title":"Histopathology"},{"key":"3250_CR37","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.14670\/hh-18-114","volume":"34","author":"T Kataoka","year":"2019","unstructured":"Kataoka T, Okudela K, Nakashima Y et al (2019) Unique expression profiles of mucin proteins in interstitial pneumonia-associated lung adenocarcinomas. Histol Histopathol 34:1243\u20131254. https:\/\/doi.org\/10.14670\/hh-18-114","journal-title":"Histol Histopathol"},{"key":"3250_CR38","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1111\/cas.14129","volume":"110","author":"T Yoshimoto","year":"2019","unstructured":"Yoshimoto T, Matsubara D, Soda M et al (2019) Mucin 21 is a key molecule involved in the incohesive growth pattern in lung adenocarcinoma. Cancer Sci 110:3006\u20133011. https:\/\/doi.org\/10.1111\/cas.14129","journal-title":"Cancer Sci"},{"key":"3250_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/path.2165","volume":"212","author":"H Sakamoto","year":"2007","unstructured":"Sakamoto H, Shimizu J, Horio Y, Ueda R, Takahashi T, Mitsudomi T, Yatabe Y (2007) Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol 212:287\u2013294. https:\/\/doi.org\/10.1002\/path.2165","journal-title":"J Pathol"},{"key":"3250_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2005.04.012","volume":"50","author":"Y Yoshida","year":"2005","unstructured":"Yoshida Y, Shibata T, Kokubu A, Tsuta K, Matsuno Y, Kanai Y, Asamura H, Tsuchiya R, Hirohashi S (2005) Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer 50:1\u20138. https:\/\/doi.org\/10.1016\/j.lungcan.2005.04.012","journal-title":"Lung Cancer"},{"key":"3250_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/jto.0b013e318168d20a","volume":"3","author":"J Soh","year":"2008","unstructured":"Soh J, Toyooka S, Ichihara S et al (2008) Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung. J Thorac Oncol 3:340\u2013347. https:\/\/doi.org\/10.1097\/jto.0b013e318168d20a","journal-title":"J Thorac Oncol"},{"key":"3250_CR42","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1158\/0008-5472.can-17-1605","volume":"77","author":"S Sivakumar","year":"2017","unstructured":"Sivakumar S, Lucas FAS, McDowell TL et al (2017) Genomic landscape of atypical adenomatous hyperplasia reveals divergent modes to lung adenocarcinoma. Cancer Res 77:6119\u20136130. https:\/\/doi.org\/10.1158\/0008-5472.can-17-1605","journal-title":"Cancer Res"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03250-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03250-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03250-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T21:06:58Z","timestamp":1650575218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-021-03250-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["3250"],"URL":"https:\/\/doi.org\/10.1007\/s00428-021-03250-y","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for the use of clinical data in research was obtained from all patients, and the study was approved by the Ethical Review Board of Tottori University, Japan (approval number: 19A165, December 4, 2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}